Center for Health Research, Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, 510530, China.
Centre for Regenerative Medicine and Health (CRMH), Hong Kong Institute of Science and Innovation, Chinese Academy of Sciences, Hong Kong, Hong Kong SAR, China.
Stem Cell Res Ther. 2024 Feb 20;15(1):48. doi: 10.1186/s13287-024-03656-w.
Allogeneic hepatocyte transplantation is an emerging approach to treat acute liver defects. However, durable engraftment of the transplanted cells remains a daunting task, as they are actively cleared by the recipient's immune system. Therefore, a detailed understanding of the innate or adaptive immune cells-derived responses against allogeneic transplanted hepatic cells is the key to rationalize cell-based therapies.
Here, we induced an acute inflammatory regenerative niche (3-96 h) on the surface of the liver by the application of cryo-injury (CI) to systematically evaluate the innate immune response against transplanted allogeneic hepatic progenitors in a sustained micro-inflammatory environment.
The resulting data highlighted that the injured site was significantly repopulated by alternating numbers of innate immune cells, including neutrophils, monocytes and Kupffer cells (KCs), from 3 to 96 h. The transplanted allo-HPs, engrafted 6 h post-injury, were collectively eliminated by the innate immune response within 24 h of transplantation. Selective depletion of the KCs demonstrated a delayed recruitment of monocytes from day 2 to day 6. In addition, the intrasplenic engraftment of the hepatic progenitors 54 h post-transplantation was dismantled by KCs, while a time-dependent better survival and translocation of the transplanted cells into the injured site could be observed in samples devoid of KCs.
Overall, this study provides evidence that KCs ablation enables a better survival and integration of allo-HPs in a sustained liver inflammatory environment, having implications for rationalizing the cell-based therapeutic interventions against liver defects.
同种异体肝细胞移植是治疗急性肝缺陷的一种新兴方法。然而,移植细胞的持久植入仍然是一项艰巨的任务,因为它们会被受者的免疫系统积极清除。因此,深入了解固有或适应性免疫细胞针对同种异体移植肝细胞的反应是合理化基于细胞的治疗的关键。
在这里,我们通过应用冷冻损伤(CI)在肝脏表面诱导急性炎症再生龛(3-96 小时),系统地评估在持续微炎症环境中对移植的同种异体肝祖细胞的固有免疫反应。
结果数据突出表明,受伤部位在 3 至 96 小时内被固有免疫细胞(包括中性粒细胞、单核细胞和库普弗细胞(KCs))的交替数量显著重新填充。在损伤后 6 小时移植的移植 allo-HPs 在移植后 24 小时内被固有免疫反应集体消除。选择性耗尽 KCs 表明单核细胞从第 2 天到第 6 天的募集延迟。此外,肝祖细胞在移植后 54 小时的脾内植入被 KCs 破坏,而在没有 KCs 的样本中,可以观察到移植细胞更好地存活和转移到受伤部位。
总的来说,这项研究提供的证据表明,KCs 消融使同种异体 HPs 在持续的肝脏炎症环境中更好地存活和整合,这对合理化针对肝缺陷的基于细胞的治疗干预具有重要意义。